Agreement sharpens AstraZeneca’s focus on priority medicines in Respiratory & Immunology portfolio (PRESS RELEASE) CAMBRIDGE, 1-Nov-2021 — /EuropaWire/ — AstraZeneca (LON: AZN), a British-Swedish multinational pharmaceutical and biotechnology company, has announced it sold the global rights of its chronic obstructive … Read the full press release
Posted in Business, Healthcare, Management, News, Pharma & Biotech
Tagged Aclidinium bromide, Almirall S.A., Alvesco, AstraZeneca, biopharmaceutical, Bretaris, Chronic obstructive pulmonary disease, COPD, Covis Pharma, Covis Pharma Group, Duaklir, Eklira, formoterol, Genuair, Genuair device, global rights, inhaler, LABA, LAMA, long-acting beta2-agonist, long-acting muscarinic antagonist, medicines, Omnaris, Pressair, respiratory medicines, rights, Tudorza, Zetonna
Every year, over 604,000 women worldwide are diagnosed with cervical cancer and approximately 342,000 die from this preventable disease, caused by Infection with high-risk human papillomavirus (HPV). As recently published in the International Journal of Cancer, the IMPACT (IMproving Primary screening And Colposcopy … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Switzerland, Technology
Tagged biomarker, cervical cancer, cervical cells, cervical pre-cancers, CINtec PLUS Cytology, Colposcopy Triage, HPV, HPV-positive women, human papillomavirus, impact, International Journal of Cancer, Pap cytology, Roche, testing
(PRESS RELEASE) GENEVA, 28-Oct-2021 — /EuropaWire/ — SGS, the world’s leading testing, inspection and certification company, has announced the expansion of its Glasgow biosafety testing facility thus helping to accelerate quality testing and reduce turnaround time for its clients. The … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Archie Lovatt, biological medicines, biologics, biologics manufacturers, biopharmaceutical, Biosafety Center of Excellence, BSL-2 cabinets, cell culture, cell therapies, COVID-19 vaccine, drug development, ELISA, gene therapies, Glasgow, Good Laboratory Practices, Good Manufacturing Practices, laboratories, monoclonal antibodies, polymerase chain reaction, real-time PCR testing, SGS, vaccines, virus detection
(PRESS RELEASE) ESPOO, 26-Oct-2021 — /EuropaWire/ — Gasum, a Finnish state-owned energy company responsible for the import of the nation’s natural gas, has announced that its biogas is used in the Post Nord’s biogas-powered vehicles for the transportation of medicines … Read the full press release
Posted in Environment, Finland, Industrial, Infrastructure & Utilities, News, Pharma & Biotech, Transportation & Logistics
Tagged biogas, biogas-powered vehicles, climate friendly, climate goals, Gasum biogas, health products, Ilmo Strömberg, Katja Toivonen, logistics, Markku Suopanki, medicines, NOx, pharmaceuticals, Post Nord, PostNord, SoX, Tamro
(PRESS RELEASE) BUCKINGHAMSHIRE, UK, 26-Oct-2021 — /EuropaWire/ — This year, Baltimore Innovations will be unveiling a new range of Humidity Balancing desiccants at Medica 2021. These HUMI-BALANCE™ Sachets are ideal for applications where products need to be protected not only … Read the full press release
Posted in Chemicals, Germany, Industrial, Marketing, News, Pharma & Biotech, Technology, United Kingdom
Tagged Alere, B-SURE™, Baltimore Innovations, Barrier Foil Pouches, BP, desiccants, GlaxoSmithKline, HUMI-BALANCE™ Sachets, Humidity Balancing desiccants, Matthew Valentine, Medica 2021, Medica Show, Moisture-control, OTC, pharmaceuticals, Philippe Depois, Silica Gel Sachets, SUPERDRYPAK™
New product specifically for the needs of aging skin Essential calcium improves overall skin integrity Halal-certified blend of 100% of plant and mineral origin serves sustainable market trends (PRESS RELEASE) DARMSTADT, 11-Oct-2021 — /EuropaWire/ — Merck (ETR: MRK), a German … Read the full press release
Posted in Germany, News, Pharma & Biotech, Science, Technology
Tagged cosmetic ingredient, dermocosmetics, epidermis, hydrophilic, mature skin, Merck, natural amino acids, Natural Moisturizing Factor, natural skin aging, RonaCare® Epintegrity, skin, skin care, Skin cells, skin hydration, Wiebke Dondras
(PRESS RELEASE) CAMBRIDGE, 29-Sep-2021 — /EuropaWire/ — AstraZeneca (LON: AZN), a British-Swedish multinational pharmaceutical and biotechnology company, has announced its rare diseases arm Alexion has exercised its option to acquire all remaining equity in Caelum Biosciences, Inc., a Clinical Stage … Read the full press release
Posted in Business, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged abnormal antibody, acquisition, AL amyloidosis, Alexion, amyloids, AstraZeneca, bone marrow, CAEL-101, Caelum Biosciences, Cardiac Amyloid Reaching for Extended Survival, CARES Phase III clinical programme, defective plasma cells, IIIb disease, immunoglobulin, light chain (AL) amyloidosis, mAb, Marc Dunoyer, Mayo stage IIIa, monoclonal antibody, rare disease
EASD 2021 – Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, is presenting new real-world data(1) of its Automated Insulin Delivery system, DBLG1. The personalized device fine-tunes insulin delivery using a state-of-the-art algorithm. Thousands of European patients have … Read the full press release
Posted in Artificial Intelligence (AI), France, Healthcare, Italy, News, Pharma & Biotech, Science, Spain, Technology
Tagged ACCU-CHEK, Accu-Chek Insight, algorithm, artificial-intelligence, Automated Insulin Delivery system, CE certificate, CGM, continuous glucose monitor, data, data visualization platform, DBLG1, DBLG1 System, Dexcom, Dexcom G6, Diabeloop, Diabetes, EASD 2021, Erik Huneker, glucose, HbA1c, Hypoglycemia, Insulin Pump, Pr. Pierre-Yves Benhamou, Roche, Stéphanie JEGU, T1D, therapeutic artificial intelligence, therapeutic artificial intelligence for diabetes management, Time In Range, TÜV Rheinland, type 1 diabetes, YourLoops
(PRESS RELEASE) CAMBRIDGE, 24-Sep-2021 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British–Swedish multinational pharmaceutical and biopharmaceutical company, has announced positive high-level results from the PROpel Phase III trial showed AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone demonstrated a … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged abiraterone, AstraZeneca, Cancer, chemotherapy, Eastern Cooperative Oncology Group, EcoG, hormones, HRR, IDMC, Independent Data Monitoring Committee, Lynparza, mCRPC, MSD, MSD Research Laboratories, Olaparib, PARP, PROpel Phase III, prostate cancer, Roy Baynes, rPFS, Susan Galbraith
New data show pre-symptomatic babies with spinal muscular atrophy (SMA) treated with Evrysdi maintained the ability to swallow Evrysdi has demonstrated consistent clinically meaningful efficacy in adults, children, and babies two months and older and is now approved in 58 countries worldwide Further … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged DMD, Duchenne muscular dystrophy, Endeavor, Evrysdi, gene therapy, Hammersmith Infant Neurological Examination, HINE-2, Levi Garraway, M.D. Ph.D, motor milestones, neuromuscular, RAINBOWFISH study, risdiplam, Roche, Sarepta, SMA, spinal muscular atrophy, SRP-9001, World Muscle Society (WMS) Virtual Congress
(PRESS RELEASE) LIVERPOOL, 21-Sep-2021 — /EuropaWire/ — University of Liverpool, one of the six original ‘red brick’ civic universities, has announced that its researchers are part of a new project to increase the number of care home staff that take … Read the full press release
Posted in Education, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Boots UK, Care England, care home staff, care homes, Day Lewis Pharmacy, Dr Alys Griffiths, Dr Amrish Patel, flu, flu vaccine, FluCare project, Liz Jones, National Care Forum, National Institute for Health Research, NIHR, pharmacists, Public Health England, researchers, UEA, University of East Anglia, University of Leicester, University of Liverpool, vaccine
Adds Rezurock™ (belumosudil) an FDA-approved, first-in-class treatment for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (cGVHD) after failure of at least two prior lines of systemic therapy (PRESS RELEASE) PARIS, 8-Sep-2021 — /EuropaWire/ — Sanofi … Read the full press release
Posted in France, Healthcare, Investment, News, Pharma & Biotech
Tagged acquisition, anti-human thymocyte antibody preparation, anti-thymocyte globulin, belumosudil, biopharmaceutical company, cGVHD, chronic graft-versus-host disease, fibrotic diseases, General Medicines, Harlan Waksal M.D., hematopoietic stem cell mobilizer, immuno-oncology therapies, immunomodulating agent, immunosuppressive, Kadmon Holdings, Mozobil®, Olivier Charmeil, plerixafor, polyclonal, Rezurock™, Sanofi, systemic therapy, Thymoglobulin®, transformative therapies, transplant portfolio
(PRESS RELEASE) CAMBRIDGE, 3-Sep-2021 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British–Swedish multinational pharmaceutical and biopharmaceutical company, has announced an agreement between the Company and the European Commission has been reached that puts an end of the legal proceedings over … Read the full press release
(PRESS RELEASE) STOCKHOLM, 2-Sep-2021 — /EuropaWire/ — Investor AB (STO: INVE-B), a Swedish investment and holding company founded in 1916, has announced its support for the Agnafit Bidco¹’s bid for Sobi (Swedish Orphan Biovitrum AB). The company has undertaken to … Read the full press release
Posted in Business, Healthcare, Investment, Management, News, Pharma & Biotech, Science, Sweden, Technology
Tagged acquisitions, Advent International, Advent International Corporation, Agnafit Bidco, Aurora Investments Pte Ltd, Biovitrum, GIC Pte Ltd., GIC Special Investments Pte Ltd, Healthcare, hematology, hemophilia, immunology, Investor AB, Johan Forssell, public offer, shares, Sobi, Swedish Orphan Biovitrum AB, Swedish Orphan International
Seanactiv™ harnesses the power of fucus vesiculosus fucoidan to limit visible signs of aging and fatigue around the eyes New ingredient helps reduce the appearance of dark circles, crow’s feet wrinkles and under-eye dullness within just one week of application Three-step action … Read the full press release
(PRESS RELEASE) LONDON, 19-Aug-2021 — /EuropaWire/ — Savills (LON: SVS), one of the world’s leading property advisors, has released its latest research on the European office space market. According to the study there has been a shift in demand for … Read the full press release
(PRESS RELEASE) AMERSFOORT, 10-Aug-2021 — /EuropaWire/ — Nutreco, leading company in the field of animal nutrition and aquafeed, has announced it is leading a EUR 21 million financing round together with Aqua-Spark and PFR Life Science, a portfolio company of … Read the full press release
Posted in Agriculture, Artificial Intelligence (AI), Environment, Investment, Netherlands, News, Pharma & Biotech, Poland, Technology
Tagged Aeromonas, AHPND, AI, Amy Novogratz, Angel investors, antibiotics, Aqua-Spark, aquaculture, Avian Pathogenic E. Coli, bacteriophages, climate goals, environmental sustainability, farmers, GHG emission, investment, Jarosław Dastych, Laëtitia Gerbe, livestock farming, Mastitis, Matthew Tebeau, Mike Velings, Montis Capital, Nutreco, Paweł Borys, PFR, PFR Life Science, Polish Development Fund, protein production, Proteon Pharmaceuticals, Pseudomonas, Rob Koremans, Salmonella, Seventure Partners, Skretting, soil pollution, sustainability, water pollution, Wojciech Szwankowski
(PRESS RELEASE) VALBY, 4-Aug-2021 — /EuropaWire/ — Lundbeck (CPH: LUN), a Danish international pharmaceutical company, has announced it will partner with Rgenta Therapeutics, Cambridge, MA-based developer of oral, small-molecule RNA-targeting medicines with an initial focus on oncology, to discover small … Read the full press release
Posted in Denmark, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged disease-causing genes, Klaus Bæk Simonsen, Lundbeck, neuroscience, Rgenta Therapeutics, RNA pathways, RNA regulation, Simon Xi, small molecule RNA modulators, small molecules, Tarek Samad, treatments for brain diseases
Application is being reviewed under the US FDA’s Real-Time Oncology Review pilot programme Based on results of the Phase III IMpower010 study, presented at ASCO, that showed adjuvant Tecentriq improved disease-free survival by more than one-third in PD-L1-positive early-stage lung cancer, compared with … Read the full press release
Posted in Healthcare, Marketing, News, Pharma & Biotech, Switzerland
Tagged atezolizumab, Cancer Immunotherapy, chemotherapy, FDA, Levi Garraway, lung cancer, non-small cell lung cancer, NSCLC, Real-Time Oncology Review, Roche, sBLA, supplemental Biologics License Application, Tecentriq®, treatment, tumours
Nanostructured biomaterial for wound dressings and dermatology to be integrated into Health Care business Evonik Venture Capital’s early investment in 2015 pays off Evonik aims to more than double the share of system solutions in Nutrition & Care by 2030 … Read the full press release
Posted in Business, Chemicals, Germany, Healthcare, Investment, News, Pharma & Biotech, Technology
Tagged acquisition, Bernhard Mohr, biomaterials, bioresorbable polymers, biotech company, biotechnologically derived cellulose, burn treatment, Dana Kralisch, Dermatology, epicite, Evonik, Friedrich-Schiller-University, hydroactive skin care, implantable medical devices, JeNaCell, medical device technologies, medical technology, medical wound dressing, microclimate, pharmaceutical drug products, RESOMER®, surgical wounds, Thomas Riermeier, treatment of chronic wounds, treatment of wounds and burns
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?